MDIC Graduate Milestones
CNY Biotech Accelerator (CNYBAC), Upstate Medical University
Medical Device Innovation Challenge (MDIC)
GRADUATE MILESTONES
MDIC Graduate Economic Impacts
Total Federal Grants: $ 9,883,762
Total Non-federal Grants/Investments: $12,822,600
Total Employees Hired: 41.5
CNYBAC provides a stipend to NYSTAR Asset, The Innovation Law Center, College of Law, Syracuse University, to conduct/prepare commercialization research reports such as patent landscape, freedom to operate, device classification and predicate device review.
2017
EndoGlow – Tissue Reveal Technology™ (https://www.endoglow.com/)
Federal Grants Awarded |
Non Gov Funds |
Employees Hired |
|
$ 330,000 (Pre-seed) $ 100,000 (FuzeHub) |
4
|
Accepted into Incubator/Accelerator and Supporting Programs: · Venture Creation Innovation Challenge · Cornell Center for Materials Research (CCMR) |
- IP submissions, University of Rochester and independent
- Prototype and preclinical testing completed with University of Rochester, 2017/2018
- Working with regional vendors for manufacturing needs
- Awarded FuzeHub Manufacturing Grants
- Named by Med Tech Outlook as a Top 10 Minimally Invasive Device Solution Company
- Accepted into Cornell Center for Materials Research (CCMR)Pit
- Hires: CEO, COO, VP of Business Development and National Sales Manager
- Won MedTech 2021 Innovative Surgical Device Company Award
- FDA device registration complete
- Cadaver labs teaching NIR in partnership with STORZ (Albany Medical Center, University of Rochester)
- PreClinic research presented at the Society of Gynecologic Surgeons 3/2022
- Working with KOLs on clinical research studies involving complex pelvic anatomy
- CNYBAC Virtual Client
Costello Prosthetic Warmers (https://www.costelloprosthetics.com/)
- Project accepted by Queen’s University Human Mobility Center student capstone project
- Participated in MedTech Annual Conference Pitch Event (October, 2017)
- Prototype tested in mountain climb under “worse case scenario” weather conditions
- Licensing proposal with large manufacturer in process
2018
Avant Medical Systems – Smart backboard
- Marketed their technology with industry partners Health O Meter and Marsden
AcceliPHI (subsidiary of ANDRO) – spinal device
- Gained patent for individuals suffering from chronic back injuries
2019
ZEPHYRx® – Spirometry Technology/Remote Patient Monitoring (https://www.zephyrx.com/)
Federal Grants Awarded |
Non Gov Funds |
Employees Hired |
$ 225,000 (NHLBI SBIR) |
|
15 |
Accepted into Incubator/Accelerator Programs: · Johnson & Johnson Innovation, JLABS |
- Received National Heart, Lung, and Blood Institute (NHLBI) SBIR grant for development and testing of breath-controlled video game for respiratory therapy
- Resident company of Johnson & Johnson Innovation, JLABS, life science incubator program
- Grew from 2 employees to 15 full-time employees
- Pivoted to bring telemedicine to lung patients during pandemic with unique software program for at-home pulmonary function testing; exploded nationally in telemedicine market
- Cystic Fibrosis Foundation purchases devices for every patient with cystic fibrosis in the US
- CNYBAC Virtual Client
- Over $2.5M in product sales/contracts
- CNYBAC Virtual Client
Halomine – Rechargeable Antimicrobial Technology (https://www.halomine.com/)
Federal Grants Awarded |
Non Gov Funds |
Employees Hired |
$ 600,000 (USDA Phase II) $1,000,000 (NSF Phase II) $ 175,000 (USDA Phase I) $2,000,000 (NYS ESD BioDefense Fund) $1,743,507 (NIH Phase II SBIR) $ 100,000 (USDA Phase I SBIR) $ 60,000 (Tech Search 3.0, US Army) $ 5,000 (Tech Search 5.0, US Army) $ 225,000 (NSF Phase I SBIR) $ 256,000 (NSF Phase I SBIR) $ 250,255 (NIH Phase I SBIR) $ 100,000 (DoD Phase I SBIR) |
$1,207,500 Pre-seed $2,885,000 SAFE |
15 |
Accepted into Incubator/Accelerator Programs: · Plug and Play Tech Center and New Materials 2020 Accelerator Program · IndieBio Inaugural NY Program |
- Cornell University spin out company
- Funding support through Cornell Center for Materials Research (CCMR)
- Joined Plug and Play Tech Center and New Materials 2020 Accelerator Program
- Accepted into IndieBio inaugural NY program
- Awarded $1M NSF SBIR Phase II grant to advance product development
- Hired Dr. Xuehong Ren, one of the world’s leading authorities on synthesized monomers polymers and N-halamine chemistries as Chief Scientific Officer
MedUx – User-centered Designed Products (https://www.medux-llc.com/)
- Accepted into MassChallenge Boston Accelerator
- Placed 2nd in ACC InVenture Prize Competition
Aurie – Reusable Intermittent Catheter System (https://livewithaurie.com/)
Federal Grants Awarded |
Non Gov Funds |
Employees Hired |
$1,776,000 (NSF) $ 500,000 (DoD) $ 100,000 (NIDILRR) |
$ 100,000 (FuzeHub) $7,250,000 (Investment) |
3.5
|
Accepted into Incubator/Accelerator Programs: · Harvard LaunchLab X GEO · VentureWell ASPIRE |
- Won FuzeHub Commercialization Competition Award
- Awarded FuzeHub Manufacturing Grants (2)
- Awarded Small Business Innovation Research (SBIR) grants from National Science Foundation and National Institute of Disability, Independent Living and Rehabilitation Research
- Raised $750K in funding through pre-seed round led by Lakehouse Ventures
- Received FDA Safer Technology Designation from FDA
- CEO Souvik Paul serves as an MDIC Mentor
- CNYBAC Virtual Client
2020
Assistance in Motion - Powered Ride-on Device for Children with Motor Impairments
(https://www.assistanceinmotion.com/)
- Received SBIR Phase I Award of $256,000
Vita Innovations – Smart mask tracking signs of clinical deterioration (https://vitainnovations.co/)
- Won A.I. Health Hackathon, Weill Cornell Medicine
- Won 46th Annual Business Today International Conference Impact Challenge
- Accepted into Blackstone & Techstars LaunchPad Fellowship
- Collaborating with Hudson Valley Advanced Manufacturing Center and MTEC
- Awarded Cornell University Student Business of the Year (2021)
- Co-winner of the Verizon and Clinton Global Initiative 2021 Social Innovation Challenge
- Accepted into MassChallenge Early-Stage National Startup Accelerator
- Accepted and awarded grant funding from Venturewell Phase I and II E-Teams Accelerator
- Accepted and awarded grant funding from American Heart Association National Business Accelerator
- Received investment and product support from Nextfab Ventures
- Completed Phase I User-Experience Trials at an academic hospital
- Accepted into Stanford Venture Studios
2021
MindTrace - 3D Neurosurgery Brain Mapping Technology (https://mindtrace.com/)
- Accepted into AlphaLab, Healthcare and life sciences accelerator
- Working with SUNY Upstate Medical University neurosurgeon and Co-director of Upstate’s brain tumor program, Dr. Harish Babu, for clinical studies
- Completed first stage of FDA Payor Communication Task Force
- Pre-sub planned with FDA to submit via Breakthrough Device Designation
- Selected by CB Insight’s as one of 150 most promising digital health companies of 2022
Rubitection - Skin Health Assessment Technology (http://rubitection.com)
- Presented at Medica Health Tech Conference
- Selected as a finalist, Women of Color Health & Wellness Pitch
- Awarded 2022 Health Equity Flex Grant, West Coast Consortium for Technology & Innovation in Pediatrics
JelikaLite (Precision Autism Technology)
Federal Grants Awarded |
Non Gov Funds |
Employees Hired |
$ 256,000 (NSF Phase I) |
$800,000 (Investment) |
4 |
Accepted into Incubator/Accelerator Programs: · Multiple Hub · Endless Frontier · M7 · NYC Healthcare Program |
- Won FuzeHub Commercialization Competition Award
- Participated in Syracuse University Student Engineering Capstone Program
- Completed pivotal clinical trial, presented results at Rutgers University Autism Conference
- Presented at 68th Annual Meeting of American Academy of Child and Adolescent Psychiatry
- Presented at Symphony Conference, Brain Foundation
- Granted FDA Breakthrough Device Designation
- Completed 2 FDA Pre Submission meetings
- Completed NSF-funded open label study, replicating 2021 clinical trial results showing autistic subject significant improvements in communications and responsiveness
- CNYBAC Virtual Client
Oratel Diagnostics - Endometriosis Diagnostic (https://www.orateldiagnostics.com/new/grav-admin/)
- Consortium for Technology & Innovation in Pediatrics (CTIP) award of $7500
- Completed first prototype using 3-D printing to evaluate our collection of saliva samples and develop standards to monitor reader performance
- Completed data analysis on pre-clinical study with Brigham and Women’s Hospital on 181 patients
- Submitted abstract to present poster at the 15th World Congress on Endometriosis May 2023
- Sponsored study at Alfred University Material Science Department to test difference in glass surfaces
- Accepted by NSF to apply for STTR grant for 2023
Dancing Eyes (Eye Movement Disorder Technology)
- SUNY Upstate Medical University faculty-founded startup company
- Completed University of Rochester regional I-Corps program
- Working with Rensselaer Polytechnic Institute (RPI), Student Engineering Capstone Program
- CNYBAC Virtual Client
2022
EndObetes – endoscopic reversible treatment devices for obesity and diabetes (https://endobetes.com/)
- Angel investment, $350K
- SBIR Phase I NIH $256K, work completed
- Strategic partnership with MicroTech Endoscopy
- Completed MedTech Innovator Accelerator Program
- Coordinated FDA Pre Submission meeting
- Preclinical testing planned with SUNY Binghamton
- SBIR Phase II application in process
PreTip – point of care EEG device for rapid screening in ED/ICU
- Upstate Medical University faculty founded company
- Phase II SBIR planning in process
- Upstate Medical University faculty-founded company
PapEasy – cervical self-screening technology (https://papeasy.com/)
- Coordinating with regulatory consultant for FDA submission
- NSF SBIR Phase I submission in process
- Working with Buffalo area contract manufacturer
- CNYBAC Virtual Client
SurgiVance – point of care rapid diagnosis through diagnostic imaging using advanced optics (https://surgivance.com/)
- Accepted into RPI student capstone program
- In process of hiring CEO
- FDA Pre-Submission in process/seed meeting scheduled
- Submitted Phase II NIH SBIR
3Dspine – 3d printed modeling pre-operative planning for adult spine procedures
- IP submitted through University at Buffalo
- FDA and reimbursement pathway initiated
- Planned STTR submission in 2023